Abu Dhabi : Abu Dhabi Health Services Company (SEHA), the UAE’s largest healthcare network, has successfully saved the life of a 7-year-old boy with a serious and complex congenital heart condition through implanting an Implantable Cardioverter Defibrillator (ICD).

Diagnosed in the womb with a very rare form of congenital cardiomyopathy, the patient – Alyan - had presented a history of losing consciousness, with his family needing to conduct cardiac compressions at home. In July 2021, he collapsed and was unresponsive for seven minutes, experiencing two episodes of exertional syncope, or fainting, with the second taking place in October.

Admitted to Sheikh Khalifa Medical City (SKMC), a SEHA-affiliated hospital, it was discovered that Alyan had a slow heart rhythm which would have been the main cause for loss of consciousness, with the potential of an opposing risk of an abnormal dangerous rapid heart rhythm. Upon this discovery, SKMC’s Consultant Cardiologist, Dr. Christopher Duke, made the initial recommendation of placing a temporary pacemaker, which was later replaced with the implantation of a defibrillator. The latter was done to manage both fast and slow heart rhythm problems, ensuring Alyan was in the best position possible to be treated for his ongoing symptoms.

Dr. Andrew David Mclean, Acting Chair of Cardiac Sciences, said: “At SKMC, we deliver the best pediatric cardiac care to the entire community, including neonates. Our comprehensive cardiac services are delivered by highly qualified pediatric cardiac experts with the support of other specialities in a multidisciplinary approach. With a team of specialized and distinguished surgeons, we were able to successfully perform this complex surgery locally, which otherwise would have had to be done overseas; keeping newborns and infants, like Alyan, close to home.”

The medical team implanted the defibrillator through a complex surgery, as Alyan was weighing-in at a mere 20kg at the time which resulted in him having incredibly thin subcutaneous tissues (the innermost layer of the skin). This meant that the surgical team had to adjust the surgery plan for best results and implant it within the axillary (located in or near the armpit) position. This form of complex surgery, called an ‘Axillary Generator Implantation’, was a part of an international research project that Dr. Duke was involved with. It ensures better tissue coverage over the larger generator, so that Alyan can be protected against any potential trauma during normal childhood activities, and with minimal scarring as an added benefit.

Dr. Christopher Duke, Consultant Cardiologist said: “Pacemaker generators are usually implanted in the anterior, or the front of the chest. However, we took into consideration other aspects such as mental, functional, and cosmetic standpoints. Alyan has already been through so much, so we wanted to ensure he had the best quality of life post-surgery, and to make him not feel self-conscious. His father had initially intended to travel abroad for treatment until they were referred to SKMC by their family friend, and I’m glad that was the case as treating him in their country of residence meant added convenience and reassurance.”

Alyan’s father praised the efforts of SKMC’s medical and surgical team, added: “I cannot express how grateful I am to Dr. Duke and the medical team at SKMC. Without a doubt, seeing your child suffer is an incredibly difficult experience. Initially, we were planning to travel abroad for treatment but to be able to keep Alyan home, close to his friends and family, played a tremendous role in his comfort and recovery throughout this entire experience. Through the support we received at SKMC, we received excellent care and continue to be incredibly thankful that we were referred to SEHA for treatment. Thank you for giving my son a chance to live a healthy, normal life.”

SKMC’s pediatric services includes the largest pediatric cardiology service in the country with a record of over 4,500 cardiac surgeries since it was established in 2007. With extensive experience in pediatric surgery in the UAE, many of these cases include the treatment of complex congenital heart diseases. Serving as the UAE’s national center for cardiac services, SKMC serves all patients throughout the seven emirates.

To find out more about SEHA’s pediatric services, book an appointment by calling 800 50.

-Ends-

About SKMC's Pediatric Cardiac Program

Opened in 2007, SKMC's Pediatric Cardiac Program serves the entire community from neonates to grown-ups with congenital heart disease. Offering comprehensive services, the Cardiac Sciences Institute of SKMC offers continuous, around the clock (24/7) pediatric cardiac service in the UAE and is the only institute providing complex neonatal cardiac repairs. Additionally, SKMC’s Pediatric Cardiac Surgery team performs surgeries to adults suffering from congenital heart disease, having been diagnosed only after becoming adults. Learn more at https://skmc.seha.ae/specialities/pediatric-cardiac-surgery/  

About SEHA:

The Abu Dhabi Health Services Company PJSC–SEHA – is an independent, public joint stock company created to develop the curative activities of the public healthcare system in Abu Dhabi. The company owns and operates all the public hospitals and clinics of the Emirate of Abu Dhabi.

SEHA is part of ADQ, one of the region’s largest holding companies with a broad portfolio of major enterprises spanning key sectors of Abu Dhabi’s diversified economy.

SEHA is committed to continuous improvement of customer care to recognized international standards and providing the community with world-class healthcare. SEHA operates 14 hospitals with over 3,385 beds, 70 ambulatory care, family care and urgent care centers and 3 blood banks. Its facilities accommodate 117,162 inpatients annually and conduct 43,262 surgeries, as well as treating more than five million outpatients.

SEHA is one of the largest integrated healthcare providers in the Middle East with more than 14,000 doctors, nurses, ancillary care, and administrative personnel. Learn more at www.seha.ae 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2022

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.